SPARC and ovarian cancer: SPARC, a putative tumour suppressor whose high expression levels were found associated with advanced stage, low differentiation, lymph node metastasis and poor prognosis of ovarian cancer,16 was also significantly overexpressed in the CAFs‐immune subtype (P < 0.001).